Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Nuvelo anticoagulant could reduce ischemia by 50%
This could be vital for the treatment of ACS because currently approved drugs do not target the proximal stages of the coagulation process. The reduction of ischemia occurred
This could be vital for the treatment of ACS because currently approved drugs do not target the proximal stages of the coagulation process. The reduction of ischemia occurred
Abbott’s goal for the trial was to establish Xience as an equal competitor with the Taxus stent. Discovering the superiority of Xience will enhance the reputation of Abbot
This is the first time that the government of India has approved a product developed from natural sources for use as a pharmaceutical grade drug. Ocufors is used
The first study 012 reported a change in the average weekly frequency of spontaneous bowel movement. Good results were also noted in the investigation of the effect of
The data was presented at the annual European Federation of Neurological Societies Congress. The 24-week study involved patients with Parkinson’s disease not adequately controlled with levodopa (L-dopa). The
This follows a similar case reported earlier from the same trial. The latest patient had four separate tumors at different sites, with a total diameter before treatment of
“The agreement between Mayo Validation Support Services and our company signals an essential step forward in Biomoda’s commitment to developing and commercializing early non invasive diagnostic tests for
The total amount of spending DHL could be handling is understood to be GBP3.7 billion pounds a year, and both parties said the 10-year contract could save the
The impact of this discovery will be important for the future of new treatments involving gene research. “It is a great achievement for ExonHit, because applications from this
The GlaxoSmithKline-sponsored study found that deaths from cervical cancer would drop by 76% with 100% coverage. Cases of cancers in the vulva and vagina could also be reduced